Tag Archives: sexual dysfunction

सुझाव है कि यौन साइड इफेक्ट फिनेस्टराइड थेरेपी में जल्दी दिखाई देते हैं तो सामान्य पर लौटें Sexual गलत है, ‘बोस्टन यूनिवर्सिटी स्कूल ऑफ मेडिसिन में शोधकर्ताओं ने कहा

SOMERSET, N.J., Aug. 26, 2015 – Twenty-five percent of men currently taking finasteride or dutasteride (brand names Proscar and Avodart) for the treatment of benign prostate enlargement (BPH), appear not to benefit from taking these medications. Those prescribed Propecia or Avodart for male pattern hair loss are also at risk for adverse events elicited by […]

साउथवेस्ट ब्रेन बैंक ने पीएफएस ब्रेन और स्पाइनल कॉर्ड डोनेशन प्रोग्राम लॉन्च किया

SOMERSET, N.J., July 15, 2015 – The Southwest Brain Bank (SWBB) in the Department of Psychiatry at the University of Texas Health Science Center in San Antonio has received its first donation of the brain and spinal cord of a post-finasteride syndrome (PFS) patient and formed a program to collect and study post-mortem human brain […]

यू.एस. नेशनल इंस्टीट्यूट ऑफ हेल्थ ने जेएफटी को जेनेटिक एंड रेयर डिसीज इन्फो सेंटर कहा है

May 19, 2015 Dear Public Health Official: The U.S. National Institutes of Health recently added post-finasteride syndrome (PFS) to its Genetic and Rare Diseases Information Center, noting that: “Studies are underway to understand the safety profile of 5-alpha reductase inhibitor drugs with respect to adverse events…and their permanency.” This federal listing of PFS comes in […]

पोस्ट-फ़ाइनस्टराइड सिंड्रोम का नैदानिक अध्ययन यूनिवर्सिटी ऑफ़ मिलानो-बियोकोका और मिलानो विश्वविद्यालय में शुरू किया गया

SOMERSET, N.J., Dec. 9, 2014 – The Post-Finasteride Syndrome Foundation today announced the funding of a third clinical study on post-finasteride syndrome (PFS), this one a collaboration between the University of Milano-Bicocca and the University of Milano, both in Italy. Titled “Rare, but Serious and Persistent, Side Effects of 5α Reductase Inhibitors (5ARI): Why Do […]

अनुस्मारक: पीएफएस लक्षणों की रिपोर्ट एफडीए मेडवेच को दें

SOMERSET, N.J., Oct. 29, 2013 – The Post-Finasteride Syndrome Foundation is reminding PFS patients to report all persistent side effects to the FDA MedWatch program. MedWatch is the U.S. Food and Drug Administration’s system for detecting safety-hazard signals for pharmaceutical products and medical devices. If a signal is detected, the FDA can issue safety alerts, […]

डॉक्टरों ने रिसर्च स्टडीज के लिए पीएफएस मरीजों की भर्ती की

SOMERSET, N.J., June 16, 2014 – Post-finasteride syndrome research initiatives at two major U.S. medical institutions, Brigham and Women’s Hospital (a Harvard Medical School Teaching Affiliate) in Boston, Mass., and Baylor College of Medicine in Houston, Texas, are currently recruiting patients for their respective studies on the condition. If you are interested in participating, or […]

फरवरी 2013 से सार इटली में पीएफएस गोलमेज अनुसंधान चर्चा

Aug. 4, 2013 Dear Friends: When we incorporated the Post-Finasteride Syndrome Foundation in July 2012, our mission was clear: To fund research on the characterization, underlying biologic mechanisms and treatments of PFS while raising public awareness of this often life-altering condition afflicting thousands of men the world over. Now, on the occasion of our one-year […]

स्टेरॉयड और तंत्रिका तंत्र पर अंतर्राष्ट्रीय बैठक में चिकित्सा शोधकर्ताओं के लिए पोस्ट-फ़ाइस्टरसाइड सिंड्रोम फाउंडेशन प्रायोजक पीएफएस राउंडटेबल

SOMERSET, N.J., Nov. 5, 2012 – The Post-Finasteride Syndrome Foundation is sponsoring a round-table discussion on PFS at the University of Milan’s 7th International Meeting on Steroids and the Nervous System conference in Torino, Italy, Feb. 19, 2013. Titled “Effects of Finasteride Treatment on the Nervous System,” the event is being organized by Roberto Melcangi, […]